Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- Should ctDNA Guide Clinical Decisions in Gastrointestinal Cancers? (Medscape)
- Avoid these physician group merger mistakes (Physicians Practice)
- Diagnosis and Management of Celiac Disease (JAMA Network)
- CMS to end Change Healthcare cyberattack financial relief program (Healthcare Dive)
- New Book Aims to Be Provider Resource, Educate Patients With IBS (GI & Endoscopy News)
- Don’t Get Thrown for a Loop: Tips for Difficult Colonoscopies (GI & Endoscopy News)
- #StopUHC campaign calls on insurer to rethink looming ‘Gold card program’ for GI endoscopy (Healio)
- Colorectal Cancer Alliance Partners with Blake Gastroenterology Associates, LLC, Gaudenzia Addiction Treatment & Recovery Services, and Penn Medicine (PR Newswire)